Patient Package Inserts: What Effects can We Expect?

McMahon G. : The patient package insert, JAMA 233: 1089, 1975.

Cooley A. : Patient package insert, JAMA 235: 372–373, Jan. 26, 1976.

Whitney H.A. : Educating the public about drugs, Drug Intell. Clin. Pharm. 9: 571, 1975.

F-D-C Reports: Hearings on HR 11617, the Rogers bill. April 5, 1976, pp. B11–B24.

Food and Drug Administration: Labeling of prescription drugs for patients Federal Register 40: 52075–52076, Nov. 7, 1975.

For example: Steiler C.J. : Letter to FDA Hearing Clerk, March 3, 1976.

Schmidt A.M. : Dimensions of change in the FDA. Paper presented at the Pharm. Advert. Seminar, Chicago, Ill., Sept. 13, 1973.

Fleckenstein L. Joubert P. Lawrence R. Patsner B. Mazzullo J. Lasagna L. : Oral contraceptive patient information. A questionnaire study of attitudes, knowledge, and preferred information sources, JAMA 235: 1331–1336, Mar. 29, 1976.

FDA: Contractor's Final Report: Survey of consumers' perceptions of patient package inserts for oral contraceptives, Sept. 1975. Available from National Technical Information Service, Springfield, Virginia, Accession PB 248–739 (cost $17 for hard copy).

Clinite J. Kabat H. : Improving patient compliance, J. Am. Pharm. Assoc. 16: 74–76;85, Apr. 1976.

Sharpe T. Mikeal R. : Patient compliance with antibiotic regimens, Am. J. Hosp. Pharm. 31: 479–484, 1974.

Sackett D. : Randomized clinical trial of strategies for improving medication compliance in primary hypertension, Lancet 1: 1205–1207, 1975.

Marston M.V. : Compliance with medical regimens: A review of the literature, Nurs. Res. 19: 312–323, 1970.

Schacter S. Singer J. : Cognitive, social and psychological determinants of emotional state, Psychol. Rev. 69: 379–399, 1962.

Shapiro A. Chassen J. Morris L. Frick R. : Placebo induced side effects, J. Oper. Psychiat. 43–46, Fall-Winter 1974.

Glaser E. Witlow G. : Experimental errors in clinical trials, Clin. Sci. 13: 199–210, 1954.